Updates from The Motley Fool

Latest updates on Merrimack Pharmaceuticals, Inc. from Fool.com.

Stock Performance

MACK vs. S&P 500 | 2 Year Performance
MACK 1-Day Stock Chart
MACK 5-Day Stock Chart
MACK 1-Month Stock Chart
MACK 3-Month Stock Chart
MACK 6-Month Stock Chart
MACK 1-Year Stock Chart
MACK 2-Year Stock Chart
MACK 5-Year Stock Chart
View Interactive MACK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Merrimack Pharmaceuticals, Inc. .
Current Price: $6.31
Prev Close: $6.54
Open: $6.45
Bid: $5.75
Ask: $7.39
Day's Range: $6.08 - $6.46
52wk Range: $5.02 - $13.00
Volume: 2,475,844
Avg Vol 1,773,721
Market Cap: $729.27M
P/E (ttm): -4.71
EPS (ttm): -$1.34
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Merrimack Pharmaceuticals, Inc. .
CAPS Rating 2 out of 5
88 Outperform
11 Underperform
CAPS All Stars
11 Outperform
6 Underperform

How do you think Merrimack Pharmaceuticals, Inc. will perform against the market?

You pick for Merrimack Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Mulroy, CEO

78% Approve

Based on 11 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Merrimack Pharmaceuticals, Inc. .

Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases with an initial focus on cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers